Tests found that the foreign matter does not pose a clinical risk to patients.

In the latest trading session, Amgen (AMGN) closed at $355.25, marking a -1.44% move from the previous day. The stock's ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Amgen stock has delivered a strong 73.5% return over the last three years, and the current checks suggest a mixed picture on ...

Quick ReadPfizer trades at 8x forward earnings with a 7% dividend yield, making it the cheaper oncology franchise versus ...

Amgen is a global leader in drug manufacturing, focusing on large-scale treatments for chronic conditions. NovoCure specializes in proprietary wearable technology to treat various forms of cancer.

Analysts' ratings for Amgen (NASDAQ:AMGN) over the last quarter vary from bullish to bearish, as provided by 11 analysts. The following table encapsulates their recent ratings, offering a glimpse into ...

Amgen is getting the ball rolling on a far-reaching new partnership that’s set to boost its profile in its hometown of Greater Los Angeles. The Big Biotech has signed on as the official biotech ...

Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination. The nationwide recall was issued by the company on June 4 ...

Product sales grew 11%, primarily driven by 14% volume growth, partially offset by 6% lower net selling price. U.S. sales rose 14%. Fourteen products delivered at least double-digit sales growth in ...

Amgen focuses on discovering and manufacturing medicines for serious diseases across several therapeutic areas. It sells its products globally, reaching customers in more than 50 countries including ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Amgen Inc.’s (NASDAQ:AMGN) Uplizna (inebilizumab-cdon) as the first and only treatment for adult patients with Immunoglobulin ...